SLC2A3 and neoplasm: Its targets have been reported to be IL-8 [29], COL1A1 [30], ADAM9 [31], HMGB1 [32], and SLC2A3 [33], and inducing mir-129-5p overexpression in tumor cells reduced malignant characteristics, including cell proliferation, migration, and invasion [29].